Alpine Immune Sciences and AbbVie Announce Option and License Agreement for the Development and Commercialization of ALPN-101 Read more
Sarepta Therapeutics and Selecta Biosciences Enter into Research License and Option Agreement Read more
Neurocrine and Takeda Announce Collaboration to Develop and Commercialize Potential Therapies for Psychiatric Disorders Read more
Novartis Cosentyx receives FDA approval for new indication to treat active non-radiographic axial spondyloarthritis Read more
Interdisciplinary Consortium Receives Grant to Develop Next-Generation Cell-Based Cancer Vaccines Read more
Lassen Therapeutics Launches to Discover and Develop Novel Antibody Therapeutics Including Lead Program Targeting IL-11 to Treat Fibrosis and Oncology Read more
PDS Biotechnology and Farmacore Biotechnology Announce Co-Development of PDS0204 COVID-19 Vaccine Read more